We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,175.00
Bid: 11,100.00
Ask: 11,250.00
Change: 0.00 (0.00%)
Spread: 150.00 (1.351%)
Open: 11,125.00
High: 11,200.00
Low: 11,200.00
Prev. Close: 11,200.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Change

10 Sep 2020 07:00

RNS Number : 5444Y
Judges Scientific PLC
10 September 2020
 

Press Release

 

 

 

Judges Scientific plc

 

("Judges Scientific")

 

Board Change

 

Judges Scientific, the group focused on acquiring and developing companies in the scientific instrument sector, announces the appointment of Lushani Kodituwakku as an independent Non-Executive Director from 23 September 2020.

Lushani is the founder and CEO of Luminii Consulting, a consulting firm specialising in strategy, Commercial Due Diligence ("CDD") and value creation. She founded Luminii in 2017 after setting up and heading the Grant Thornton Strategy and CDD team in 2008 and holding various other senior roles with KPMG, Frost & Sullivan, PMSI and Neovian Partners.

Lushani has delivered several complex strategy & CDD projects since 1999 to large corporates, SMEs, private equity, venture capital and banks in the UK, Europe and USA looking to invest, enter new markets, diversify, redefine their business strategy and business models, making her one of the most experienced CDD and strategy advisors in the UK.

Lushani holds a Bachelor of Science (BSc) in Economics with first-class honours, and a Master of Research (MRes) in Management and Organisational Behaviour.

Lushani will also join the Remuneration committee, replacing Alex Hambro. The Board committees will comprise as follows:

Remuneration committee - Charles Holroyd (chair), Ralph Elman, Lushani Kodituwakku

Audit committee - Ralph Elman (chair), Charles Holroyd, Ralph Cohen

 

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Lushani to the Group. Lushani brings extensive expertise in strategy, CDD and value creation. We look forward to her guidance over the coming years as the Group continues to execute its buy and build growth strategy."

 

 

Judges Scientific

 

 

David Cicurel, CEO

Brad Ormsby, Group FD

  Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Joint Broker)

 

 

Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Alma (Financial Public Relations)

Rebecca Sanders-Hewett

Sam Modlin

 

 

Tel: +44 (0) 20 3100 2222

 

 

 

 

Tel: +44 (0) 20 3405 0205

 

 

Regulatory Information

The following disclosures in relation to the appointment of Lushani Dileeka Kodituwakku, aged 46, are required pursuant to Schedule 2(g) of the AIM Rules for Companies:

 

 Current directorships and partnerships:

Past directorships and partnerships held over the last five years:

Anukampa Bhikkhuni Project

 

Ceylon Tea Centre Limited

 

Luminii Consulting

 

 

Lushani Kodituwakku has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.  

 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 18 businesses acquired since it was re-admitted to AIM in 2005.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEAAIIAIII
Date   Source Headline
7th Nov 20192:38 pmRNSDirector/PDMR Shareholding
1st Nov 201910:49 amRNSTotal Voting Rights
9th Oct 201910:20 amRNSDirector/PDMR Shareholding
23rd Sep 20193:49 pmRNSHolding(s) in Company
23rd Sep 20198:45 amRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results
16th Sep 20191:39 pmRNSHolding(s) in Company
9th Sep 201911:26 amRNSDirector/PDMR Shareholding
27th Aug 20191:18 pmRNSHolding(s) in Company
7th Aug 201910:39 amRNSDirector/PDMR Shareholding
2nd Aug 20194:01 pmRNSHolding(s) in Company
22nd Jul 20197:00 amRNSAppointment of Liberum as Joint Broker
22nd Jul 20197:00 amRNSTrading Update and Notice of Interim Results
17th Jul 201911:43 amRNSHolding(s) in Company
17th Jul 201911:41 amRNSHolding(s) in Company
12th Jul 20199:23 amRNSDirector/PDMR Shareholding
9th Jul 20195:17 pmRNSDirector/PDMR Shareholding
28th Jun 20194:27 pmRNSHolding(s) in Company
7th Jun 20199:14 amRNSDirector/PDMR Shareholding
5th Jun 201912:05 pmRNSBlock listing Interim Review
3rd Jun 201911:57 amRNSTotal Voting Rights
22nd May 20191:39 pmRNSResult of AGM
16th May 20195:37 pmRNSDirector/PDMR Shareholding
9th May 20194:14 pmRNSDirector/PDMR Shareholding
1st May 20197:00 amRNSTotal Voting Rights
29th Apr 20194:21 pmRNSNotice of AGM
9th Apr 20197:00 amRNSHolding(s) in Company
8th Apr 20195:53 pmRNSDirector/PDMR Shareholding
5th Apr 20199:30 amRNSDirector/PDMR Shareholding
1st Apr 20195:59 pmRNSHolding(s) in Company
1st Apr 201912:35 pmRNSTotal Voting Rights
22nd Mar 201911:54 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
7th Mar 20192:22 pmRNSDirector/PDMR Shareholding
28th Feb 20197:00 amRNSTotal Voting Rights
7th Feb 20192:34 pmRNSDirector/PDMR Shareholding
5th Feb 20197:00 amRNSHolding(s) in Company
17th Jan 20197:00 amRNSTrading Statement and Notice of Final Results
9th Jan 20197:00 amRNSDirector/PDMR Shareholding
21st Dec 20183:21 pmRNSDirector/PDMR Shareholding
7th Dec 20187:00 amRNSDirector/PDMR Shareholding
4th Dec 201812:41 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
21st Nov 20187:00 amRNSTrading Update
15th Nov 20187:00 amRNSBlock listing Interim Review
13th Nov 20185:49 pmRNSHolding(s) in Company
6th Nov 201811:51 amRNSDirector/PDMR Shareholding
30th Oct 201810:00 amRNSTotal Voting Rights
9th Oct 20182:09 pmRNSDirector/PDMR Shareholding
18th Sep 20187:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.